nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—Sulfonamides—Zonisamide—epilepsy syndrome	0.383	1	CiPCiCtD
Acetazolamide—AQP1—epilepsy syndrome	0.158	0.739	CbGaD
Acetazolamide—CA4—epilepsy syndrome	0.0559	0.261	CbGaD
Acetazolamide—CA3—Lacosamide—epilepsy syndrome	0.0365	0.131	CbGbCtD
Acetazolamide—CA3—Zonisamide—epilepsy syndrome	0.0232	0.0831	CbGbCtD
Acetazolamide—CA14—Lacosamide—epilepsy syndrome	0.0151	0.0542	CbGbCtD
Acetazolamide—CA6—Lacosamide—epilepsy syndrome	0.0144	0.0515	CbGbCtD
Acetazolamide—CA5B—Lacosamide—epilepsy syndrome	0.0125	0.0449	CbGbCtD
Acetazolamide—CA9—Lacosamide—epilepsy syndrome	0.0108	0.0385	CbGbCtD
Acetazolamide—CA1—Lacosamide—epilepsy syndrome	0.0101	0.036	CbGbCtD
Acetazolamide—CA14—Zonisamide—epilepsy syndrome	0.00964	0.0345	CbGbCtD
Acetazolamide—CA4—Lacosamide—epilepsy syndrome	0.00946	0.0339	CbGbCtD
Acetazolamide—CA6—Zonisamide—epilepsy syndrome	0.00915	0.0328	CbGbCtD
Acetazolamide—CA5A—Zonisamide—epilepsy syndrome	0.00915	0.0328	CbGbCtD
Acetazolamide—CA2—Lacosamide—epilepsy syndrome	0.00869	0.0311	CbGbCtD
Acetazolamide—CA5B—Zonisamide—epilepsy syndrome	0.00798	0.0286	CbGbCtD
Acetazolamide—CA7—Zonisamide—epilepsy syndrome	0.00798	0.0286	CbGbCtD
Acetazolamide—CA9—Zonisamide—epilepsy syndrome	0.00685	0.0245	CbGbCtD
Acetazolamide—CA12—Zonisamide—epilepsy syndrome	0.00685	0.0245	CbGbCtD
Acetazolamide—CA6—Topiramate—epilepsy syndrome	0.00667	0.0239	CbGbCtD
Acetazolamide—CA5A—Topiramate—epilepsy syndrome	0.00667	0.0239	CbGbCtD
Acetazolamide—CA1—Zonisamide—epilepsy syndrome	0.00641	0.0229	CbGbCtD
Acetazolamide—CA4—Zonisamide—epilepsy syndrome	0.00602	0.0216	CbGbCtD
Acetazolamide—CA5B—Topiramate—epilepsy syndrome	0.00581	0.0208	CbGbCtD
Acetazolamide—CA7—Topiramate—epilepsy syndrome	0.00581	0.0208	CbGbCtD
Acetazolamide—CA2—Zonisamide—epilepsy syndrome	0.00554	0.0198	CbGbCtD
Acetazolamide—CA9—Topiramate—epilepsy syndrome	0.00499	0.0179	CbGbCtD
Acetazolamide—CA12—Topiramate—epilepsy syndrome	0.00499	0.0179	CbGbCtD
Acetazolamide—CA1—Topiramate—epilepsy syndrome	0.00467	0.0167	CbGbCtD
Acetazolamide—CA4—Topiramate—epilepsy syndrome	0.00439	0.0157	CbGbCtD
Acetazolamide—CA2—Topiramate—epilepsy syndrome	0.00403	0.0144	CbGbCtD
Acetazolamide—SLC22A6—Valproic Acid—epilepsy syndrome	0.00172	0.00616	CbGbCtD
Acetazolamide—CA6—ear—epilepsy syndrome	0.00163	0.0944	CbGeAlD
Acetazolamide—CA3—ear—epilepsy syndrome	0.00154	0.0894	CbGeAlD
Acetazolamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00122	0.00438	CbGbCtD
Acetazolamide—CYP3A4—Felbamate—epilepsy syndrome	0.00114	0.00407	CbGbCtD
Acetazolamide—CYP3A4—Trimethadione—epilepsy syndrome	0.00114	0.00407	CbGbCtD
Acetazolamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00107	0.00383	CbGbCtD
Acetazolamide—CYP3A4—Clonazepam—epilepsy syndrome	0.000968	0.00346	CbGbCtD
Acetazolamide—CYP3A4—Clobazam—epilepsy syndrome	0.000928	0.00332	CbGbCtD
Acetazolamide—Methazolamide—CA4—epilepsy syndrome	0.000853	0.632	CrCbGaD
Acetazolamide—CYP3A4—Rufinamide—epilepsy syndrome	0.000789	0.00282	CbGbCtD
Acetazolamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.000769	0.00275	CbGbCtD
Acetazolamide—CYP3A4—Primidone—epilepsy syndrome	0.000718	0.00257	CbGbCtD
Acetazolamide—CYP3A4—Phenytoin—epilepsy syndrome	0.000689	0.00247	CbGbCtD
Acetazolamide—CYP3A4—Propofol—epilepsy syndrome	0.000643	0.0023	CbGbCtD
Acetazolamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.000615	0.0022	CbGbCtD
Acetazolamide—CYP3A4—Midazolam—epilepsy syndrome	0.000606	0.00217	CbGbCtD
Acetazolamide—CYP3A4—Diazepam—epilepsy syndrome	0.000583	0.00209	CbGbCtD
Acetazolamide—CYP3A4—Zonisamide—epilepsy syndrome	0.000569	0.00204	CbGbCtD
Acetazolamide—AQP1—forebrain—epilepsy syndrome	0.000549	0.0318	CbGeAlD
Acetazolamide—AQP1—telencephalon—epilepsy syndrome	0.000505	0.0292	CbGeAlD
Acetazolamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.000459	0.00164	CbGbCtD
Acetazolamide—CA4—ganglion—epilepsy syndrome	0.000421	0.0244	CbGeAlD
Acetazolamide—CYP3A4—Topiramate—epilepsy syndrome	0.000414	0.00148	CbGbCtD
Acetazolamide—CA3—forebrain—epilepsy syndrome	0.000403	0.0233	CbGeAlD
Acetazolamide—AQP1—medulla oblongata—epilepsy syndrome	0.000397	0.023	CbGeAlD
Acetazolamide—CA3—telencephalon—epilepsy syndrome	0.00037	0.0214	CbGeAlD
Acetazolamide—AQP1—midbrain—epilepsy syndrome	0.000363	0.021	CbGeAlD
Acetazolamide—AQP1—spinal cord—epilepsy syndrome	0.000354	0.0205	CbGeAlD
Acetazolamide—CA14—telencephalon—epilepsy syndrome	0.000336	0.0195	CbGeAlD
Acetazolamide—CA4—hindbrain—epilepsy syndrome	0.000319	0.0185	CbGeAlD
Acetazolamide—AQP1—head—epilepsy syndrome	0.000315	0.0182	CbGeAlD
Acetazolamide—AQP1—nervous system—epilepsy syndrome	0.000298	0.0173	CbGeAlD
Acetazolamide—CA7—midbrain—epilepsy syndrome	0.00029	0.0168	CbGeAlD
Acetazolamide—AQP1—central nervous system—epilepsy syndrome	0.000287	0.0166	CbGeAlD
Acetazolamide—Methazolamide—CYP2C19—epilepsy syndrome	0.000286	0.212	CrCbGaD
Acetazolamide—CA12—forebrain—epilepsy syndrome	0.000285	0.0165	CbGeAlD
Acetazolamide—AQP1—cerebellum—epilepsy syndrome	0.000281	0.0162	CbGeAlD
Acetazolamide—CA2—hindbrain—epilepsy syndrome	0.000265	0.0153	CbGeAlD
Acetazolamide—CA14—medulla oblongata—epilepsy syndrome	0.000264	0.0153	CbGeAlD
Acetazolamide—CA12—telencephalon—epilepsy syndrome	0.000262	0.0152	CbGeAlD
Acetazolamide—CA6—head—epilepsy syndrome	0.000244	0.0141	CbGeAlD
Acetazolamide—CA14—midbrain—epilepsy syndrome	0.000242	0.014	CbGeAlD
Acetazolamide—CA14—spinal cord—epilepsy syndrome	0.000236	0.0136	CbGeAlD
Acetazolamide—CA3—head—epilepsy syndrome	0.000231	0.0133	CbGeAlD
Acetazolamide—AQP1—brain—epilepsy syndrome	0.000228	0.0132	CbGeAlD
Acetazolamide—CA1—forebrain—epilepsy syndrome	0.000226	0.0131	CbGeAlD
Acetazolamide—CA7—cerebellum—epilepsy syndrome	0.000224	0.013	CbGeAlD
Acetazolamide—CA3—nervous system—epilepsy syndrome	0.000219	0.0127	CbGeAlD
Acetazolamide—Methazolamide—CYP2D6—epilepsy syndrome	0.000212	0.157	CrCbGaD
Acetazolamide—CA3—central nervous system—epilepsy syndrome	0.000211	0.0122	CbGeAlD
Acetazolamide—CA1—telencephalon—epilepsy syndrome	0.000208	0.012	CbGeAlD
Acetazolamide—CA9—cerebellum—epilepsy syndrome	0.000197	0.0114	CbGeAlD
Acetazolamide—CA14—cerebellum—epilepsy syndrome	0.000187	0.0108	CbGeAlD
Acetazolamide—CA4—brainstem—epilepsy syndrome	0.000183	0.0106	CbGeAlD
Acetazolamide—CA7—brain—epilepsy syndrome	0.000182	0.0105	CbGeAlD
Acetazolamide—CA4—forebrain—epilepsy syndrome	0.000177	0.0102	CbGeAlD
Acetazolamide—CA3—brain—epilepsy syndrome	0.000167	0.00967	CbGeAlD
Acetazolamide—CA12—head—epilepsy syndrome	0.000163	0.00945	CbGeAlD
Acetazolamide—CA4—telencephalon—epilepsy syndrome	0.000162	0.0094	CbGeAlD
Acetazolamide—CA12—nervous system—epilepsy syndrome	0.000155	0.00896	CbGeAlD
Acetazolamide—CA14—brain—epilepsy syndrome	0.000152	0.00878	CbGeAlD
Acetazolamide—CA2—brainstem—epilepsy syndrome	0.000152	0.00878	CbGeAlD
Acetazolamide—CA12—central nervous system—epilepsy syndrome	0.000149	0.00863	CbGeAlD
Acetazolamide—CA5B—head—epilepsy syndrome	0.000147	0.00848	CbGeAlD
Acetazolamide—CA2—forebrain—epilepsy syndrome	0.000146	0.00847	CbGeAlD
Acetazolamide—CA1—spinal cord—epilepsy syndrome	0.000146	0.00842	CbGeAlD
Acetazolamide—CA5B—nervous system—epilepsy syndrome	0.000139	0.00804	CbGeAlD
Acetazolamide—CA2—telencephalon—epilepsy syndrome	0.000135	0.00779	CbGeAlD
Acetazolamide—CA5B—central nervous system—epilepsy syndrome	0.000134	0.00774	CbGeAlD
Acetazolamide—SLC22A6—brain—epilepsy syndrome	0.000132	0.00764	CbGeAlD
Acetazolamide—CA1—head—epilepsy syndrome	0.000129	0.00749	CbGeAlD
Acetazolamide—CA4—medulla oblongata—epilepsy syndrome	0.000128	0.00738	CbGeAlD
Acetazolamide—CA1—nervous system—epilepsy syndrome	0.000123	0.0071	CbGeAlD
Acetazolamide—CA12—brain—epilepsy syndrome	0.000118	0.00685	CbGeAlD
Acetazolamide—CA1—central nervous system—epilepsy syndrome	0.000118	0.00683	CbGeAlD
Acetazolamide—CA4—midbrain—epilepsy syndrome	0.000117	0.00675	CbGeAlD
Acetazolamide—CA4—spinal cord—epilepsy syndrome	0.000114	0.00658	CbGeAlD
Acetazolamide—CA5B—brain—epilepsy syndrome	0.000106	0.00614	CbGeAlD
Acetazolamide—CA2—medulla oblongata—epilepsy syndrome	0.000106	0.00612	CbGeAlD
Acetazolamide—CA4—head—epilepsy syndrome	0.000101	0.00585	CbGeAlD
Acetazolamide—CA2—midbrain—epilepsy syndrome	9.67e-05	0.0056	CbGeAlD
Acetazolamide—CA4—nervous system—epilepsy syndrome	9.59e-05	0.00555	CbGeAlD
Acetazolamide—CA2—spinal cord—epilepsy syndrome	9.44e-05	0.00546	CbGeAlD
Acetazolamide—CA1—brain—epilepsy syndrome	9.38e-05	0.00543	CbGeAlD
Acetazolamide—CA4—central nervous system—epilepsy syndrome	9.23e-05	0.00534	CbGeAlD
Acetazolamide—CA4—cerebellum—epilepsy syndrome	9.02e-05	0.00522	CbGeAlD
Acetazolamide—CA2—head—epilepsy syndrome	8.39e-05	0.00485	CbGeAlD
Acetazolamide—CA2—nervous system—epilepsy syndrome	7.95e-05	0.0046	CbGeAlD
Acetazolamide—CA2—central nervous system—epilepsy syndrome	7.66e-05	0.00443	CbGeAlD
Acetazolamide—CA2—cerebellum—epilepsy syndrome	7.48e-05	0.00433	CbGeAlD
Acetazolamide—CA4—brain—epilepsy syndrome	7.33e-05	0.00424	CbGeAlD
Acetazolamide—CA2—brain—epilepsy syndrome	6.08e-05	0.00352	CbGeAlD
Acetazolamide—CYP3A4—nervous system—epilepsy syndrome	5.13e-05	0.00297	CbGeAlD
Acetazolamide—CYP3A4—central nervous system—epilepsy syndrome	4.94e-05	0.00286	CbGeAlD
Acetazolamide—Decreased appetite—Zonisamide—epilepsy syndrome	4.36e-05	0.000727	CcSEcCtD
Acetazolamide—Shock—Lamotrigine—epilepsy syndrome	4.35e-05	0.000727	CcSEcCtD
Acetazolamide—Thrombocytopenia—Lamotrigine—epilepsy syndrome	4.33e-05	0.000723	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	4.33e-05	0.000722	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Gabapentin—epilepsy syndrome	4.32e-05	0.000722	CcSEcCtD
Acetazolamide—Fatigue—Zonisamide—epilepsy syndrome	4.32e-05	0.000721	CcSEcCtD
Acetazolamide—Paraesthesia—Phenytoin—epilepsy syndrome	4.31e-05	0.000719	CcSEcCtD
Acetazolamide—Somnolence—Clonazepam—epilepsy syndrome	4.29e-05	0.000717	CcSEcCtD
Acetazolamide—Urticaria—Vigabatrin—epilepsy syndrome	4.27e-05	0.000713	CcSEcCtD
Acetazolamide—Somnolence—Phenytoin—epilepsy syndrome	4.26e-05	0.000712	CcSEcCtD
Acetazolamide—Dyspepsia—Clonazepam—epilepsy syndrome	4.25e-05	0.00071	CcSEcCtD
Acetazolamide—Body temperature increased—Vigabatrin—epilepsy syndrome	4.25e-05	0.000709	CcSEcCtD
Acetazolamide—Somnolence—Oxcarbazepine—epilepsy syndrome	4.24e-05	0.000708	CcSEcCtD
Acetazolamide—Nausea—Clobazam—epilepsy syndrome	4.24e-05	0.000708	CcSEcCtD
Acetazolamide—Asthenia—Propofol—epilepsy syndrome	4.24e-05	0.000708	CcSEcCtD
Acetazolamide—Erythema multiforme—Pregabalin—epilepsy syndrome	4.23e-05	0.000706	CcSEcCtD
Acetazolamide—Dyspepsia—Phenytoin—epilepsy syndrome	4.22e-05	0.000705	CcSEcCtD
Acetazolamide—Dysgeusia—Valproic Acid—epilepsy syndrome	4.22e-05	0.000704	CcSEcCtD
Acetazolamide—Feeling abnormal—Felbamate—epilepsy syndrome	4.22e-05	0.000704	CcSEcCtD
Acetazolamide—Urticaria—Diazepam—epilepsy syndrome	4.2e-05	0.000701	CcSEcCtD
Acetazolamide—Dyspepsia—Oxcarbazepine—epilepsy syndrome	4.2e-05	0.000701	CcSEcCtD
Acetazolamide—Decreased appetite—Clonazepam—epilepsy syndrome	4.2e-05	0.000701	CcSEcCtD
Acetazolamide—Tinnitus—Pregabalin—epilepsy syndrome	4.17e-05	0.000697	CcSEcCtD
Acetazolamide—Decreased appetite—Phenytoin—epilepsy syndrome	4.17e-05	0.000696	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	4.17e-05	0.000696	CcSEcCtD
Acetazolamide—Fatigue—Clonazepam—epilepsy syndrome	4.16e-05	0.000695	CcSEcCtD
Acetazolamide—Flushing—Pregabalin—epilepsy syndrome	4.15e-05	0.000693	CcSEcCtD
Acetazolamide—Asthenia—Midazolam—epilepsy syndrome	4.15e-05	0.000693	CcSEcCtD
Acetazolamide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	4.15e-05	0.000692	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	4.14e-05	0.000691	CcSEcCtD
Acetazolamide—Fatigue—Phenytoin—epilepsy syndrome	4.14e-05	0.00069	CcSEcCtD
Acetazolamide—Feeling abnormal—Zonisamide—epilepsy syndrome	4.13e-05	0.000689	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	4.12e-05	0.000688	CcSEcCtD
Acetazolamide—Fatigue—Oxcarbazepine—epilepsy syndrome	4.11e-05	0.000687	CcSEcCtD
Acetazolamide—Paraesthesia—Carbamazepine—epilepsy syndrome	4.11e-05	0.000686	CcSEcCtD
Acetazolamide—Asthenia—Levetiracetam—epilepsy syndrome	4.1e-05	0.000684	CcSEcCtD
Acetazolamide—Hypoaesthesia—Gabapentin—epilepsy syndrome	4.08e-05	0.000682	CcSEcCtD
Acetazolamide—Somnolence—Carbamazepine—epilepsy syndrome	4.07e-05	0.00068	CcSEcCtD
Acetazolamide—Urticaria—Felbamate—epilepsy syndrome	4.07e-05	0.000679	CcSEcCtD
Acetazolamide—Body temperature increased—Felbamate—epilepsy syndrome	4.05e-05	0.000676	CcSEcCtD
Acetazolamide—Diarrhoea—Propofol—epilepsy syndrome	4.04e-05	0.000675	CcSEcCtD
Acetazolamide—Dyspepsia—Carbamazepine—epilepsy syndrome	4.03e-05	0.000673	CcSEcCtD
Acetazolamide—Ill-defined disorder—Valproic Acid—epilepsy syndrome	4e-05	0.000667	CcSEcCtD
Acetazolamide—Urticaria—Zonisamide—epilepsy syndrome	3.98e-05	0.000665	CcSEcCtD
Acetazolamide—Decreased appetite—Carbamazepine—epilepsy syndrome	3.98e-05	0.000665	CcSEcCtD
Acetazolamide—Feeling abnormal—Clonazepam—epilepsy syndrome	3.98e-05	0.000664	CcSEcCtD
Acetazolamide—Paraesthesia—Lamotrigine—epilepsy syndrome	3.97e-05	0.000663	CcSEcCtD
Acetazolamide—Body temperature increased—Zonisamide—epilepsy syndrome	3.96e-05	0.000661	CcSEcCtD
Acetazolamide—Agitation—Valproic Acid—epilepsy syndrome	3.96e-05	0.000661	CcSEcCtD
Acetazolamide—Asthenia—Fosphenytoin—epilepsy syndrome	3.95e-05	0.00066	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	3.95e-05	0.00066	CcSEcCtD
Acetazolamide—Feeling abnormal—Phenytoin—epilepsy syndrome	3.95e-05	0.00066	CcSEcCtD
Acetazolamide—Fatigue—Carbamazepine—epilepsy syndrome	3.95e-05	0.000659	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Topiramate—epilepsy syndrome	3.94e-05	0.000657	CcSEcCtD
Acetazolamide—Somnolence—Lamotrigine—epilepsy syndrome	3.93e-05	0.000657	CcSEcCtD
Acetazolamide—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	3.93e-05	0.000656	CcSEcCtD
Acetazolamide—Dizziness—Propofol—epilepsy syndrome	3.91e-05	0.000653	CcSEcCtD
Acetazolamide—Diarrhoea—Levetiracetam—epilepsy syndrome	3.91e-05	0.000652	CcSEcCtD
Acetazolamide—Dyspepsia—Lamotrigine—epilepsy syndrome	3.89e-05	0.00065	CcSEcCtD
Acetazolamide—Malaise—Valproic Acid—epilepsy syndrome	3.89e-05	0.000649	CcSEcCtD
Acetazolamide—Erythema multiforme—Gabapentin—epilepsy syndrome	3.88e-05	0.000648	CcSEcCtD
Acetazolamide—Leukopenia—Valproic Acid—epilepsy syndrome	3.86e-05	0.000644	CcSEcCtD
Acetazolamide—Asthenia—Vigabatrin—epilepsy syndrome	3.85e-05	0.000644	CcSEcCtD
Acetazolamide—Decreased appetite—Lamotrigine—epilepsy syndrome	3.85e-05	0.000642	CcSEcCtD
Acetazolamide—Urticaria—Clonazepam—epilepsy syndrome	3.84e-05	0.00064	CcSEcCtD
Acetazolamide—Tinnitus—Gabapentin—epilepsy syndrome	3.83e-05	0.000639	CcSEcCtD
Acetazolamide—Dizziness—Midazolam—epilepsy syndrome	3.82e-05	0.000638	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	3.82e-05	0.000638	CcSEcCtD
Acetazolamide—Body temperature increased—Clonazepam—epilepsy syndrome	3.82e-05	0.000637	CcSEcCtD
Acetazolamide—Fatigue—Lamotrigine—epilepsy syndrome	3.81e-05	0.000637	CcSEcCtD
Acetazolamide—Dysgeusia—Pregabalin—epilepsy syndrome	3.81e-05	0.000637	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	3.81e-05	0.000636	CcSEcCtD
Acetazolamide—Urticaria—Phenytoin—epilepsy syndrome	3.81e-05	0.000636	CcSEcCtD
Acetazolamide—Asthenia—Diazepam—epilepsy syndrome	3.79e-05	0.000634	CcSEcCtD
Acetazolamide—Body temperature increased—Phenytoin—epilepsy syndrome	3.79e-05	0.000633	CcSEcCtD
Acetazolamide—Urticaria—Oxcarbazepine—epilepsy syndrome	3.79e-05	0.000633	CcSEcCtD
Acetazolamide—Dizziness—Levetiracetam—epilepsy syndrome	3.78e-05	0.00063	CcSEcCtD
Acetazolamide—Feeling abnormal—Carbamazepine—epilepsy syndrome	3.77e-05	0.00063	CcSEcCtD
Acetazolamide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	3.77e-05	0.00063	CcSEcCtD
Acetazolamide—Diarrhoea—Fosphenytoin—epilepsy syndrome	3.77e-05	0.00063	CcSEcCtD
Acetazolamide—Vomiting—Propofol—epilepsy syndrome	3.76e-05	0.000627	CcSEcCtD
Acetazolamide—Headache—Propofol—epilepsy syndrome	3.7e-05	0.000618	CcSEcCtD
Acetazolamide—Vomiting—Midazolam—epilepsy syndrome	3.68e-05	0.000614	CcSEcCtD
Acetazolamide—Diarrhoea—Vigabatrin—epilepsy syndrome	3.68e-05	0.000614	CcSEcCtD
Acetazolamide—Asthenia—Felbamate—epilepsy syndrome	3.67e-05	0.000613	CcSEcCtD
Acetazolamide—Haematuria—Topiramate—epilepsy syndrome	3.67e-05	0.000612	CcSEcCtD
Acetazolamide—Feeling abnormal—Lamotrigine—epilepsy syndrome	3.65e-05	0.000609	CcSEcCtD
Acetazolamide—Dizziness—Fosphenytoin—epilepsy syndrome	3.64e-05	0.000608	CcSEcCtD
Acetazolamide—Urticaria—Carbamazepine—epilepsy syndrome	3.64e-05	0.000607	CcSEcCtD
Acetazolamide—Vomiting—Levetiracetam—epilepsy syndrome	3.63e-05	0.000606	CcSEcCtD
Acetazolamide—Discomfort—Valproic Acid—epilepsy syndrome	3.62e-05	0.000605	CcSEcCtD
Acetazolamide—Headache—Midazolam—epilepsy syndrome	3.62e-05	0.000605	CcSEcCtD
Acetazolamide—Body temperature increased—Carbamazepine—epilepsy syndrome	3.62e-05	0.000604	CcSEcCtD
Acetazolamide—Diarrhoea—Diazepam—epilepsy syndrome	3.62e-05	0.000604	CcSEcCtD
Acetazolamide—Ill-defined disorder—Pregabalin—epilepsy syndrome	3.61e-05	0.000603	CcSEcCtD
Acetazolamide—Asthenia—Zonisamide—epilepsy syndrome	3.59e-05	0.0006	CcSEcCtD
Acetazolamide—Agranulocytosis—Topiramate—epilepsy syndrome	3.59e-05	0.000599	CcSEcCtD
Acetazolamide—Agitation—Pregabalin—epilepsy syndrome	3.58e-05	0.000598	CcSEcCtD
Acetazolamide—Headache—Levetiracetam—epilepsy syndrome	3.58e-05	0.000597	CcSEcCtD
Acetazolamide—Dizziness—Vigabatrin—epilepsy syndrome	3.55e-05	0.000593	CcSEcCtD
Acetazolamide—Confusional state—Valproic Acid—epilepsy syndrome	3.55e-05	0.000592	CcSEcCtD
Acetazolamide—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.52e-05	0.000587	CcSEcCtD
Acetazolamide—Urticaria—Lamotrigine—epilepsy syndrome	3.52e-05	0.000587	CcSEcCtD
Acetazolamide—Malaise—Pregabalin—epilepsy syndrome	3.51e-05	0.000586	CcSEcCtD
Acetazolamide—Nausea—Propofol—epilepsy syndrome	3.51e-05	0.000586	CcSEcCtD
Acetazolamide—Vomiting—Fosphenytoin—epilepsy syndrome	3.5e-05	0.000585	CcSEcCtD
Acetazolamide—Diarrhoea—Felbamate—epilepsy syndrome	3.5e-05	0.000585	CcSEcCtD
Acetazolamide—Body temperature increased—Lamotrigine—epilepsy syndrome	3.5e-05	0.000584	CcSEcCtD
Acetazolamide—Dysgeusia—Gabapentin—epilepsy syndrome	3.5e-05	0.000584	CcSEcCtD
Acetazolamide—Dizziness—Diazepam—epilepsy syndrome	3.5e-05	0.000584	CcSEcCtD
Acetazolamide—Leukopenia—Pregabalin—epilepsy syndrome	3.49e-05	0.000582	CcSEcCtD
Acetazolamide—Asthenia—Clonazepam—epilepsy syndrome	3.46e-05	0.000578	CcSEcCtD
Acetazolamide—Headache—Fosphenytoin—epilepsy syndrome	3.45e-05	0.000576	CcSEcCtD
Acetazolamide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.44e-05	0.000575	CcSEcCtD
Acetazolamide—Asthenia—Phenytoin—epilepsy syndrome	3.44e-05	0.000575	CcSEcCtD
Acetazolamide—Nausea—Midazolam—epilepsy syndrome	3.43e-05	0.000573	CcSEcCtD
Acetazolamide—Hypoaesthesia—Topiramate—epilepsy syndrome	3.43e-05	0.000573	CcSEcCtD
Acetazolamide—Diarrhoea—Zonisamide—epilepsy syndrome	3.43e-05	0.000572	CcSEcCtD
Acetazolamide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.42e-05	0.000572	CcSEcCtD
Acetazolamide—Vomiting—Vigabatrin—epilepsy syndrome	3.42e-05	0.00057	CcSEcCtD
Acetazolamide—Nausea—Levetiracetam—epilepsy syndrome	3.39e-05	0.000566	CcSEcCtD
Acetazolamide—Dizziness—Felbamate—epilepsy syndrome	3.38e-05	0.000565	CcSEcCtD
Acetazolamide—Convulsion—Pregabalin—epilepsy syndrome	3.37e-05	0.000563	CcSEcCtD
Acetazolamide—Headache—Vigabatrin—epilepsy syndrome	3.37e-05	0.000562	CcSEcCtD
Acetazolamide—Vomiting—Diazepam—epilepsy syndrome	3.36e-05	0.000561	CcSEcCtD
Acetazolamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.31e-05	0.000553	CcSEcCtD
Acetazolamide—Dizziness—Zonisamide—epilepsy syndrome	3.31e-05	0.000553	CcSEcCtD
Acetazolamide—Headache—Diazepam—epilepsy syndrome	3.31e-05	0.000553	CcSEcCtD
Acetazolamide—Diarrhoea—Clonazepam—epilepsy syndrome	3.3e-05	0.000552	CcSEcCtD
Acetazolamide—Asthenia—Carbamazepine—epilepsy syndrome	3.28e-05	0.000548	CcSEcCtD
Acetazolamide—Agitation—Gabapentin—epilepsy syndrome	3.28e-05	0.000548	CcSEcCtD
Acetazolamide—Diarrhoea—Phenytoin—epilepsy syndrome	3.28e-05	0.000548	CcSEcCtD
Acetazolamide—Discomfort—Pregabalin—epilepsy syndrome	3.28e-05	0.000547	CcSEcCtD
Acetazolamide—Nausea—Fosphenytoin—epilepsy syndrome	3.27e-05	0.000547	CcSEcCtD
Acetazolamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.26e-05	0.000545	CcSEcCtD
Acetazolamide—Erythema multiforme—Topiramate—epilepsy syndrome	3.26e-05	0.000545	CcSEcCtD
Acetazolamide—Vomiting—Felbamate—epilepsy syndrome	3.25e-05	0.000543	CcSEcCtD
Acetazolamide—Malaise—Gabapentin—epilepsy syndrome	3.22e-05	0.000538	CcSEcCtD
Acetazolamide—Tinnitus—Topiramate—epilepsy syndrome	3.22e-05	0.000537	CcSEcCtD
Acetazolamide—Headache—Felbamate—epilepsy syndrome	3.21e-05	0.000535	CcSEcCtD
Acetazolamide—Confusional state—Pregabalin—epilepsy syndrome	3.21e-05	0.000535	CcSEcCtD
Acetazolamide—Flushing—Topiramate—epilepsy syndrome	3.2e-05	0.000535	CcSEcCtD
Acetazolamide—Leukopenia—Gabapentin—epilepsy syndrome	3.2e-05	0.000534	CcSEcCtD
Acetazolamide—Dizziness—Clonazepam—epilepsy syndrome	3.19e-05	0.000533	CcSEcCtD
Acetazolamide—Nausea—Vigabatrin—epilepsy syndrome	3.19e-05	0.000533	CcSEcCtD
Acetazolamide—Vomiting—Zonisamide—epilepsy syndrome	3.19e-05	0.000532	CcSEcCtD
Acetazolamide—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.18e-05	0.000531	CcSEcCtD
Acetazolamide—Asthenia—Lamotrigine—epilepsy syndrome	3.17e-05	0.00053	CcSEcCtD
Acetazolamide—Dizziness—Phenytoin—epilepsy syndrome	3.17e-05	0.00053	CcSEcCtD
Acetazolamide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.16e-05	0.000527	CcSEcCtD
Acetazolamide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.15e-05	0.000527	CcSEcCtD
Acetazolamide—Nausea—Diazepam—epilepsy syndrome	3.14e-05	0.000524	CcSEcCtD
Acetazolamide—Headache—Zonisamide—epilepsy syndrome	3.14e-05	0.000524	CcSEcCtD
Acetazolamide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.13e-05	0.000523	CcSEcCtD
Acetazolamide—Shock—Pregabalin—epilepsy syndrome	3.13e-05	0.000522	CcSEcCtD
Acetazolamide—Somnolence—Valproic Acid—epilepsy syndrome	3.13e-05	0.000522	CcSEcCtD
Acetazolamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.11e-05	0.00052	CcSEcCtD
Acetazolamide—Dyspepsia—Valproic Acid—epilepsy syndrome	3.1e-05	0.000517	CcSEcCtD
Acetazolamide—Convulsion—Gabapentin—epilepsy syndrome	3.09e-05	0.000517	CcSEcCtD
Acetazolamide—Vomiting—Clonazepam—epilepsy syndrome	3.07e-05	0.000513	CcSEcCtD
Acetazolamide—Decreased appetite—Valproic Acid—epilepsy syndrome	3.06e-05	0.00051	CcSEcCtD
Acetazolamide—Vomiting—Phenytoin—epilepsy syndrome	3.05e-05	0.000509	CcSEcCtD
Acetazolamide—Nausea—Felbamate—epilepsy syndrome	3.04e-05	0.000508	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.04e-05	0.000507	CcSEcCtD
Acetazolamide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.03e-05	0.000506	CcSEcCtD
Acetazolamide—Fatigue—Valproic Acid—epilepsy syndrome	3.03e-05	0.000506	CcSEcCtD
Acetazolamide—Dizziness—Carbamazepine—epilepsy syndrome	3.03e-05	0.000505	CcSEcCtD
Acetazolamide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.03e-05	0.000505	CcSEcCtD
Acetazolamide—Headache—Clonazepam—epilepsy syndrome	3.02e-05	0.000505	CcSEcCtD
Acetazolamide—Headache—Phenytoin—epilepsy syndrome	3e-05	0.000502	CcSEcCtD
Acetazolamide—Discomfort—Gabapentin—epilepsy syndrome	3e-05	0.000502	CcSEcCtD
Acetazolamide—Headache—Oxcarbazepine—epilepsy syndrome	2.99e-05	0.000499	CcSEcCtD
Acetazolamide—Nausea—Zonisamide—epilepsy syndrome	2.98e-05	0.000497	CcSEcCtD
Acetazolamide—Dysgeusia—Topiramate—epilepsy syndrome	2.94e-05	0.000491	CcSEcCtD
Acetazolamide—Confusional state—Gabapentin—epilepsy syndrome	2.94e-05	0.000491	CcSEcCtD
Acetazolamide—Dizziness—Lamotrigine—epilepsy syndrome	2.93e-05	0.000489	CcSEcCtD
Acetazolamide—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.91e-05	0.000487	CcSEcCtD
Acetazolamide—Vomiting—Carbamazepine—epilepsy syndrome	2.91e-05	0.000486	CcSEcCtD
Acetazolamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.9e-05	0.000484	CcSEcCtD
Acetazolamide—Nausea—Clonazepam—epilepsy syndrome	2.87e-05	0.000479	CcSEcCtD
Acetazolamide—Headache—Carbamazepine—epilepsy syndrome	2.87e-05	0.000479	CcSEcCtD
Acetazolamide—Shock—Gabapentin—epilepsy syndrome	2.87e-05	0.000479	CcSEcCtD
Acetazolamide—Paraesthesia—Pregabalin—epilepsy syndrome	2.85e-05	0.000477	CcSEcCtD
Acetazolamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.85e-05	0.000477	CcSEcCtD
Acetazolamide—Nausea—Phenytoin—epilepsy syndrome	2.85e-05	0.000476	CcSEcCtD
Acetazolamide—Nausea—Oxcarbazepine—epilepsy syndrome	2.83e-05	0.000473	CcSEcCtD
Acetazolamide—Somnolence—Pregabalin—epilepsy syndrome	2.83e-05	0.000472	CcSEcCtD
Acetazolamide—Vomiting—Lamotrigine—epilepsy syndrome	2.81e-05	0.00047	CcSEcCtD
Acetazolamide—Urticaria—Valproic Acid—epilepsy syndrome	2.79e-05	0.000466	CcSEcCtD
Acetazolamide—Ill-defined disorder—Topiramate—epilepsy syndrome	2.79e-05	0.000465	CcSEcCtD
Acetazolamide—Body temperature increased—Valproic Acid—epilepsy syndrome	2.78e-05	0.000464	CcSEcCtD
Acetazolamide—Headache—Lamotrigine—epilepsy syndrome	2.77e-05	0.000463	CcSEcCtD
Acetazolamide—Decreased appetite—Pregabalin—epilepsy syndrome	2.76e-05	0.000461	CcSEcCtD
Acetazolamide—Agitation—Topiramate—epilepsy syndrome	2.76e-05	0.000461	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.74e-05	0.000458	CcSEcCtD
Acetazolamide—Fatigue—Pregabalin—epilepsy syndrome	2.74e-05	0.000458	CcSEcCtD
Acetazolamide—Nausea—Carbamazepine—epilepsy syndrome	2.72e-05	0.000454	CcSEcCtD
Acetazolamide—Malaise—Topiramate—epilepsy syndrome	2.71e-05	0.000452	CcSEcCtD
Acetazolamide—Leukopenia—Topiramate—epilepsy syndrome	2.69e-05	0.000449	CcSEcCtD
Acetazolamide—Nausea—Lamotrigine—epilepsy syndrome	2.63e-05	0.000439	CcSEcCtD
Acetazolamide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.62e-05	0.000437	CcSEcCtD
Acetazolamide—Paraesthesia—Gabapentin—epilepsy syndrome	2.62e-05	0.000437	CcSEcCtD
Acetazolamide—Convulsion—Topiramate—epilepsy syndrome	2.6e-05	0.000435	CcSEcCtD
Acetazolamide—Somnolence—Gabapentin—epilepsy syndrome	2.59e-05	0.000433	CcSEcCtD
Acetazolamide—Dyspepsia—Gabapentin—epilepsy syndrome	2.57e-05	0.000428	CcSEcCtD
Acetazolamide—Decreased appetite—Gabapentin—epilepsy syndrome	2.53e-05	0.000423	CcSEcCtD
Acetazolamide—Discomfort—Topiramate—epilepsy syndrome	2.53e-05	0.000422	CcSEcCtD
Acetazolamide—Urticaria—Pregabalin—epilepsy syndrome	2.53e-05	0.000422	CcSEcCtD
Acetazolamide—Asthenia—Valproic Acid—epilepsy syndrome	2.52e-05	0.000421	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.52e-05	0.00042	CcSEcCtD
Acetazolamide—Fatigue—Gabapentin—epilepsy syndrome	2.51e-05	0.00042	CcSEcCtD
Acetazolamide—Body temperature increased—Pregabalin—epilepsy syndrome	2.51e-05	0.00042	CcSEcCtD
Acetazolamide—Confusional state—Topiramate—epilepsy syndrome	2.47e-05	0.000413	CcSEcCtD
Acetazolamide—Shock—Topiramate—epilepsy syndrome	2.41e-05	0.000403	CcSEcCtD
Acetazolamide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.41e-05	0.000402	CcSEcCtD
Acetazolamide—Feeling abnormal—Gabapentin—epilepsy syndrome	2.4e-05	0.000401	CcSEcCtD
Acetazolamide—Thrombocytopenia—Topiramate—epilepsy syndrome	2.4e-05	0.000401	CcSEcCtD
Acetazolamide—Dizziness—Valproic Acid—epilepsy syndrome	2.33e-05	0.000388	CcSEcCtD
Acetazolamide—Urticaria—Gabapentin—epilepsy syndrome	2.32e-05	0.000387	CcSEcCtD
Acetazolamide—Body temperature increased—Gabapentin—epilepsy syndrome	2.3e-05	0.000385	CcSEcCtD
Acetazolamide—Asthenia—Pregabalin—epilepsy syndrome	2.28e-05	0.000381	CcSEcCtD
Acetazolamide—Vomiting—Valproic Acid—epilepsy syndrome	2.24e-05	0.000373	CcSEcCtD
Acetazolamide—Headache—Valproic Acid—epilepsy syndrome	2.2e-05	0.000368	CcSEcCtD
Acetazolamide—Paraesthesia—Topiramate—epilepsy syndrome	2.2e-05	0.000368	CcSEcCtD
Acetazolamide—Somnolence—Topiramate—epilepsy syndrome	2.18e-05	0.000364	CcSEcCtD
Acetazolamide—Diarrhoea—Pregabalin—epilepsy syndrome	2.17e-05	0.000363	CcSEcCtD
Acetazolamide—Dyspepsia—Topiramate—epilepsy syndrome	2.16e-05	0.00036	CcSEcCtD
Acetazolamide—Decreased appetite—Topiramate—epilepsy syndrome	2.13e-05	0.000356	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.12e-05	0.000353	CcSEcCtD
Acetazolamide—Fatigue—Topiramate—epilepsy syndrome	2.11e-05	0.000353	CcSEcCtD
Acetazolamide—Dizziness—Pregabalin—epilepsy syndrome	2.1e-05	0.000351	CcSEcCtD
Acetazolamide—Asthenia—Gabapentin—epilepsy syndrome	2.09e-05	0.000349	CcSEcCtD
Acetazolamide—Nausea—Valproic Acid—epilepsy syndrome	2.09e-05	0.000349	CcSEcCtD
Acetazolamide—Vomiting—Pregabalin—epilepsy syndrome	2.02e-05	0.000337	CcSEcCtD
Acetazolamide—Feeling abnormal—Topiramate—epilepsy syndrome	2.02e-05	0.000337	CcSEcCtD
Acetazolamide—Diarrhoea—Gabapentin—epilepsy syndrome	1.99e-05	0.000333	CcSEcCtD
Acetazolamide—Headache—Pregabalin—epilepsy syndrome	1.99e-05	0.000332	CcSEcCtD
Acetazolamide—Urticaria—Topiramate—epilepsy syndrome	1.95e-05	0.000325	CcSEcCtD
Acetazolamide—Body temperature increased—Topiramate—epilepsy syndrome	1.94e-05	0.000324	CcSEcCtD
Acetazolamide—Dizziness—Gabapentin—epilepsy syndrome	1.93e-05	0.000322	CcSEcCtD
Acetazolamide—Nausea—Pregabalin—epilepsy syndrome	1.89e-05	0.000315	CcSEcCtD
Acetazolamide—Vomiting—Gabapentin—epilepsy syndrome	1.85e-05	0.000309	CcSEcCtD
Acetazolamide—Headache—Gabapentin—epilepsy syndrome	1.83e-05	0.000305	CcSEcCtD
Acetazolamide—Asthenia—Topiramate—epilepsy syndrome	1.76e-05	0.000294	CcSEcCtD
Acetazolamide—Nausea—Gabapentin—epilepsy syndrome	1.73e-05	0.000289	CcSEcCtD
Acetazolamide—Diarrhoea—Topiramate—epilepsy syndrome	1.68e-05	0.00028	CcSEcCtD
Acetazolamide—Dizziness—Topiramate—epilepsy syndrome	1.62e-05	0.000271	CcSEcCtD
Acetazolamide—Vomiting—Topiramate—epilepsy syndrome	1.56e-05	0.00026	CcSEcCtD
Acetazolamide—Headache—Topiramate—epilepsy syndrome	1.54e-05	0.000257	CcSEcCtD
Acetazolamide—Nausea—Topiramate—epilepsy syndrome	1.46e-05	0.000243	CcSEcCtD
Acetazolamide—CA5A—Metabolism—SLC2A1—epilepsy syndrome	5.88e-06	0.000131	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—POMC—epilepsy syndrome	5.85e-06	0.00013	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PLCB1—epilepsy syndrome	5.81e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PLCB1—epilepsy syndrome	5.81e-06	0.000129	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.8e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TH—epilepsy syndrome	5.79e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TH—epilepsy syndrome	5.79e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TXNRD1—epilepsy syndrome	5.79e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—KCNJ11—epilepsy syndrome	5.78e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CHRM3—epilepsy syndrome	5.78e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ADRA2A—epilepsy syndrome	5.78e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ADRA2A—epilepsy syndrome	5.78e-06	0.000129	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—BCHE—epilepsy syndrome	5.75e-06	0.000128	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—BCHE—epilepsy syndrome	5.75e-06	0.000128	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP2D6—epilepsy syndrome	5.62e-06	0.000125	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AQP1—epilepsy syndrome	5.62e-06	0.000125	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC2A1—epilepsy syndrome	5.49e-06	0.000122	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC2A1—epilepsy syndrome	5.49e-06	0.000122	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PLCB1—epilepsy syndrome	5.43e-06	0.000121	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PLCB1—epilepsy syndrome	5.43e-06	0.000121	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TH—epilepsy syndrome	5.41e-06	0.00012	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TH—epilepsy syndrome	5.41e-06	0.00012	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ADRA2A—epilepsy syndrome	5.35e-06	0.000119	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—ALB—epilepsy syndrome	5.33e-06	0.000119	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—BCHE—epilepsy syndrome	5.33e-06	0.000119	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.31e-06	0.000118	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—JUN—epilepsy syndrome	5.3e-06	0.000118	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.17e-06	0.000115	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ABCG2—epilepsy syndrome	5.13e-06	0.000114	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CHRM3—epilepsy syndrome	5.08e-06	0.000113	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—KCNJ11—epilepsy syndrome	5.08e-06	0.000113	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC2A1—epilepsy syndrome	5.08e-06	0.000113	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—POMC—epilepsy syndrome	5.07e-06	0.000113	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PLCB1—epilepsy syndrome	5.03e-06	0.000112	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TH—epilepsy syndrome	5.01e-06	0.000112	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP2C19—epilepsy syndrome	5e-06	0.000111	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP11A1—epilepsy syndrome	4.97e-06	0.000111	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—HMOX1—epilepsy syndrome	4.96e-06	0.00011	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ABCG2—epilepsy syndrome	4.92e-06	0.000109	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CAT—epilepsy syndrome	4.89e-06	0.000109	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—HMOX1—epilepsy syndrome	4.83e-06	0.000108	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—HMOX1—epilepsy syndrome	4.83e-06	0.000108	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP2C19—epilepsy syndrome	4.79e-06	0.000107	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CAT—epilepsy syndrome	4.77e-06	0.000106	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CAT—epilepsy syndrome	4.77e-06	0.000106	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ABCB1—epilepsy syndrome	4.76e-06	0.000106	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP11A1—epilepsy syndrome	4.76e-06	0.000106	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ABCG2—epilepsy syndrome	4.71e-06	0.000105	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTGS2—epilepsy syndrome	4.66e-06	0.000104	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ABCB1—epilepsy syndrome	4.64e-06	0.000103	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ABCB1—epilepsy syndrome	4.64e-06	0.000103	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—epilepsy syndrome	4.63e-06	0.000103	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ALB—epilepsy syndrome	4.62e-06	0.000103	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP2C19—epilepsy syndrome	4.59e-06	0.000102	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP11A1—epilepsy syndrome	4.56e-06	0.000102	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—HMOX1—epilepsy syndrome	4.51e-06	0.000101	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—HMOX1—epilepsy syndrome	4.51e-06	0.000101	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP2D6—epilepsy syndrome	4.48e-06	9.98e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CAT—epilepsy syndrome	4.45e-06	9.92e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CAT—epilepsy syndrome	4.45e-06	9.92e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GPX1—epilepsy syndrome	4.43e-06	9.86e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.4e-06	9.79e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ABCB1—epilepsy syndrome	4.33e-06	9.65e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ABCB1—epilepsy syndrome	4.33e-06	9.65e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GPX1—epilepsy syndrome	4.31e-06	9.61e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GPX1—epilepsy syndrome	4.31e-06	9.61e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP2D6—epilepsy syndrome	4.3e-06	9.57e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ADRA2A—epilepsy syndrome	4.27e-06	9.5e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—BCHE—epilepsy syndrome	4.25e-06	9.46e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.2e-06	9.34e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—HMOX1—epilepsy syndrome	4.18e-06	9.31e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ABCG2—epilepsy syndrome	4.14e-06	9.23e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CAT—epilepsy syndrome	4.13e-06	9.19e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP2D6—epilepsy syndrome	4.12e-06	9.17e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ADRA2A—epilepsy syndrome	4.09e-06	9.11e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.08e-06	9.08e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—BCHE—epilepsy syndrome	4.07e-06	9.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.06e-06	9.03e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC2A1—epilepsy syndrome	4.05e-06	9.03e-05	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTGS2—epilepsy syndrome	4.04e-06	9.01e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP2C19—epilepsy syndrome	4.04e-06	8.99e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GPX1—epilepsy syndrome	4.03e-06	8.97e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GPX1—epilepsy syndrome	4.03e-06	8.97e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP11A1—epilepsy syndrome	4.01e-06	8.94e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ABCB1—epilepsy syndrome	4.01e-06	8.94e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PLCB1—epilepsy syndrome	4.01e-06	8.93e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TH—epilepsy syndrome	3.99e-06	8.9e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.97e-06	8.85e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.95e-06	8.8e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ADRA2A—epilepsy syndrome	3.92e-06	8.73e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.92e-06	8.73e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—BCHE—epilepsy syndrome	3.91e-06	8.7e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.9e-06	8.68e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC2A1—epilepsy syndrome	3.89e-06	8.65e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AGT—epilepsy syndrome	3.88e-06	8.64e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PLCB1—epilepsy syndrome	3.84e-06	8.56e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TH—epilepsy syndrome	3.83e-06	8.53e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—APOE—epilepsy syndrome	3.8e-06	8.47e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AGT—epilepsy syndrome	3.78e-06	8.42e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AGT—epilepsy syndrome	3.78e-06	8.42e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GPX1—epilepsy syndrome	3.73e-06	8.31e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC2A1—epilepsy syndrome	3.73e-06	8.3e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—APOE—epilepsy syndrome	3.71e-06	8.25e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—APOE—epilepsy syndrome	3.71e-06	8.25e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PLCB1—epilepsy syndrome	3.68e-06	8.21e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TH—epilepsy syndrome	3.67e-06	8.18e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP2D6—epilepsy syndrome	3.62e-06	8.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.57e-06	7.94e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AGT—epilepsy syndrome	3.53e-06	7.86e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AGT—epilepsy syndrome	3.53e-06	7.86e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.52e-06	7.83e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APOE—epilepsy syndrome	3.46e-06	7.71e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APOE—epilepsy syndrome	3.46e-06	7.71e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.45e-06	7.69e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ADRA2A—epilepsy syndrome	3.45e-06	7.68e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—BCHE—epilepsy syndrome	3.43e-06	7.65e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.42e-06	7.62e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HMOX1—epilepsy syndrome	3.33e-06	7.43e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.31e-06	7.38e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CAT—epilepsy syndrome	3.29e-06	7.33e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.29e-06	7.32e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC2A1—epilepsy syndrome	3.28e-06	7.29e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AGT—epilepsy syndrome	3.27e-06	7.29e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—POMC—epilepsy syndrome	3.27e-06	7.28e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PLCB1—epilepsy syndrome	3.24e-06	7.21e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TH—epilepsy syndrome	3.23e-06	7.19e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOE—epilepsy syndrome	3.21e-06	7.14e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ABCB1—epilepsy syndrome	3.2e-06	7.13e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HMOX1—epilepsy syndrome	3.2e-06	7.12e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—POMC—epilepsy syndrome	3.18e-06	7.09e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—POMC—epilepsy syndrome	3.18e-06	7.09e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CAT—epilepsy syndrome	3.15e-06	7.02e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ABCB1—epilepsy syndrome	3.07e-06	6.83e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HMOX1—epilepsy syndrome	3.06e-06	6.82e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CAT—epilepsy syndrome	3.02e-06	6.73e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ALB—epilepsy syndrome	2.98e-06	6.63e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GPX1—epilepsy syndrome	2.97e-06	6.63e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—POMC—epilepsy syndrome	2.97e-06	6.62e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—POMC—epilepsy syndrome	2.97e-06	6.62e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ABCB1—epilepsy syndrome	2.94e-06	6.55e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ALB—epilepsy syndrome	2.9e-06	6.46e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ALB—epilepsy syndrome	2.9e-06	6.46e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GPX1—epilepsy syndrome	2.85e-06	6.35e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—POMC—epilepsy syndrome	2.75e-06	6.13e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GPX1—epilepsy syndrome	2.73e-06	6.09e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.72e-06	6.06e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ALB—epilepsy syndrome	2.71e-06	6.03e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ALB—epilepsy syndrome	2.71e-06	6.03e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HMOX1—epilepsy syndrome	2.69e-06	6e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CAT—epilepsy syndrome	2.66e-06	5.92e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AGT—epilepsy syndrome	2.61e-06	5.81e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—epilepsy syndrome	2.61e-06	5.8e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ABCB1—epilepsy syndrome	2.59e-06	5.76e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOE—epilepsy syndrome	2.56e-06	5.69e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—epilepsy syndrome	2.54e-06	5.66e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—epilepsy syndrome	2.54e-06	5.66e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ALB—epilepsy syndrome	2.51e-06	5.59e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AGT—epilepsy syndrome	2.5e-06	5.57e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOE—epilepsy syndrome	2.45e-06	5.46e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GPX1—epilepsy syndrome	2.4e-06	5.35e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AGT—epilepsy syndrome	2.4e-06	5.34e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—epilepsy syndrome	2.37e-06	5.28e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—epilepsy syndrome	2.37e-06	5.28e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOE—epilepsy syndrome	2.35e-06	5.23e-05	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—epilepsy syndrome	2.34e-06	5.22e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—epilepsy syndrome	2.2e-06	4.89e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—POMC—epilepsy syndrome	2.2e-06	4.89e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AGT—epilepsy syndrome	2.11e-06	4.69e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—POMC—epilepsy syndrome	2.11e-06	4.69e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.07e-06	4.61e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOE—epilepsy syndrome	2.07e-06	4.6e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.06e-06	4.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.06e-06	4.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.06e-06	4.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.06e-06	4.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.06e-06	4.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.06e-06	4.59e-05	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—epilepsy syndrome	2.03e-06	4.53e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—POMC—epilepsy syndrome	2.02e-06	4.49e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALB—epilepsy syndrome	2e-06	4.46e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALB—epilepsy syndrome	1.92e-06	4.27e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.88e-06	4.2e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.88e-06	4.2e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.88e-06	4.2e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.88e-06	4.2e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALB—epilepsy syndrome	1.84e-06	4.1e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—POMC—epilepsy syndrome	1.77e-06	3.95e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.75e-06	3.9e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.75e-06	3.9e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—epilepsy syndrome	1.75e-06	3.9e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.75e-06	3.89e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—epilepsy syndrome	1.68e-06	3.74e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.65e-06	3.67e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALB—epilepsy syndrome	1.62e-06	3.6e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—epilepsy syndrome	1.61e-06	3.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.56e-06	3.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.56e-06	3.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.56e-06	3.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.56e-06	3.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.56e-06	3.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.43e-06	3.18e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.43e-06	3.18e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.43e-06	3.18e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—epilepsy syndrome	1.42e-06	3.15e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.37e-06	3.06e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.33e-06	2.96e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.33e-06	2.96e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—epilepsy syndrome	1.31e-06	2.92e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—epilepsy syndrome	1.28e-06	2.84e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—epilepsy syndrome	1.28e-06	2.84e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.25e-06	2.78e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.21e-06	2.7e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—epilepsy syndrome	1.19e-06	2.65e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—epilepsy syndrome	1.19e-06	2.65e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.18e-06	2.64e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.18e-06	2.64e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.13e-06	2.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.13e-06	2.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.1e-06	2.46e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—epilepsy syndrome	1.1e-06	2.46e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.08e-06	2.41e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.06e-06	2.36e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.04e-06	2.32e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	9.75e-07	2.17e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	9.46e-07	2.11e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—epilepsy syndrome	8.8e-07	1.96e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.56e-07	1.91e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.56e-07	1.91e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—epilepsy syndrome	8.44e-07	1.88e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—epilepsy syndrome	8.09e-07	1.8e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—epilepsy syndrome	7.11e-07	1.58e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.98e-07	1.55e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.8e-07	1.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.76e-07	1.5e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.1e-07	1.36e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.8e-07	1.29e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.78e-07	1.29e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.51e-07	1.23e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.45e-07	1.21e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TH—epilepsy syndrome	5.43e-07	1.21e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.54e-07	1.01e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.47e-07	9.97e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.35e-07	9.69e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.05e-07	9.01e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.55e-07	7.9e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.48e-07	7.74e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.99e-07	6.65e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.72e-07	6.06e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.38e-07	5.31e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.2e-07	2.67e-06	CbGpPWpGaD
